| Dr Michael Vickery, DO | |
|
1101 W University Dr, Rochester, MI 48307-1863 | |
| (248) 652-5000 | |
| Not Available |
| Full Name | Dr Michael Vickery |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 27 Years |
| Location | 1101 W University Dr, Rochester, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285675322 | NPI | - | NPPES |
| 114409786 | Medicaid | MI | |
| MV013667 | Other | MI | BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 5101013667 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America Llc | 6608056171 | 575 |
News Archive
A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.
The first disease-modifying drugs are expected to launch from 2013, radically changing the way Alzheimer's disease is treated. With the potential to successfully slow or halt the progression of Alzheimer's, blockbuster revenues are beckoning for such pipeline drugs, claims independent market analyst, Datamonitor.
A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health scientists and colleagues at Mount Sinai's Icahn School of Medicine.
Caffeine is the most widely used psychoactive substance and is part of the daily diet of most people, whether they know it or not. Caffeine is being added to more products, including energy drinks and snack foods, with no regulations requiring the amount of caffeine to be included on the product label.
eClinicalWorks®, a market leader in ambulatory clinical systems, today announced the opening of new locations in Pleasanton, Calif., and New York City, both set to open in October. Currently, the company is headquartered in Westborough, Mass., and has additional offices in New York City and Alpharetta, Ga. The Bay Area location will provide a West coast presence and focus on implementation.
› Verified 4 days ago
| Entity Name | Rochester Emergency Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730108705 PECOS PAC ID: 7911894688 Enrollment ID: O20040228000239 |
News Archive
A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.
The first disease-modifying drugs are expected to launch from 2013, radically changing the way Alzheimer's disease is treated. With the potential to successfully slow or halt the progression of Alzheimer's, blockbuster revenues are beckoning for such pipeline drugs, claims independent market analyst, Datamonitor.
A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health scientists and colleagues at Mount Sinai's Icahn School of Medicine.
Caffeine is the most widely used psychoactive substance and is part of the daily diet of most people, whether they know it or not. Caffeine is being added to more products, including energy drinks and snack foods, with no regulations requiring the amount of caffeine to be included on the product label.
eClinicalWorks®, a market leader in ambulatory clinical systems, today announced the opening of new locations in Pleasanton, Calif., and New York City, both set to open in October. Currently, the company is headquartered in Westborough, Mass., and has additional offices in New York City and Alpharetta, Ga. The Bay Area location will provide a West coast presence and focus on implementation.
› Verified 4 days ago
| Entity Name | Ascension Providence Rochester Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437272523 PECOS PAC ID: 8820994098 Enrollment ID: O20040316000704 |
News Archive
A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.
The first disease-modifying drugs are expected to launch from 2013, radically changing the way Alzheimer's disease is treated. With the potential to successfully slow or halt the progression of Alzheimer's, blockbuster revenues are beckoning for such pipeline drugs, claims independent market analyst, Datamonitor.
A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health scientists and colleagues at Mount Sinai's Icahn School of Medicine.
Caffeine is the most widely used psychoactive substance and is part of the daily diet of most people, whether they know it or not. Caffeine is being added to more products, including energy drinks and snack foods, with no regulations requiring the amount of caffeine to be included on the product label.
eClinicalWorks®, a market leader in ambulatory clinical systems, today announced the opening of new locations in Pleasanton, Calif., and New York City, both set to open in October. Currently, the company is headquartered in Westborough, Mass., and has additional offices in New York City and Alpharetta, Ga. The Bay Area location will provide a West coast presence and focus on implementation.
› Verified 4 days ago
| Entity Name | Kalamazoo Emergency Associates, Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942251244 PECOS PAC ID: 5890685473 Enrollment ID: O20040317001078 |
News Archive
A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.
The first disease-modifying drugs are expected to launch from 2013, radically changing the way Alzheimer's disease is treated. With the potential to successfully slow or halt the progression of Alzheimer's, blockbuster revenues are beckoning for such pipeline drugs, claims independent market analyst, Datamonitor.
A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health scientists and colleagues at Mount Sinai's Icahn School of Medicine.
Caffeine is the most widely used psychoactive substance and is part of the daily diet of most people, whether they know it or not. Caffeine is being added to more products, including energy drinks and snack foods, with no regulations requiring the amount of caffeine to be included on the product label.
eClinicalWorks®, a market leader in ambulatory clinical systems, today announced the opening of new locations in Pleasanton, Calif., and New York City, both set to open in October. Currently, the company is headquartered in Westborough, Mass., and has additional offices in New York City and Alpharetta, Ga. The Bay Area location will provide a West coast presence and focus on implementation.
› Verified 4 days ago
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912687328 PECOS PAC ID: 6608056171 Enrollment ID: O20230815000906 |
News Archive
A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.
The first disease-modifying drugs are expected to launch from 2013, radically changing the way Alzheimer's disease is treated. With the potential to successfully slow or halt the progression of Alzheimer's, blockbuster revenues are beckoning for such pipeline drugs, claims independent market analyst, Datamonitor.
A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health scientists and colleagues at Mount Sinai's Icahn School of Medicine.
Caffeine is the most widely used psychoactive substance and is part of the daily diet of most people, whether they know it or not. Caffeine is being added to more products, including energy drinks and snack foods, with no regulations requiring the amount of caffeine to be included on the product label.
eClinicalWorks®, a market leader in ambulatory clinical systems, today announced the opening of new locations in Pleasanton, Calif., and New York City, both set to open in October. Currently, the company is headquartered in Westborough, Mass., and has additional offices in New York City and Alpharetta, Ga. The Bay Area location will provide a West coast presence and focus on implementation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Vickery, DO 2724 Trafford Rd, Royal Oak, MI 48073-4418 Ph: () - | Dr Michael Vickery, DO 1101 W University Dr, Rochester, MI 48307-1863 Ph: (248) 652-5000 |
News Archive
A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.
The first disease-modifying drugs are expected to launch from 2013, radically changing the way Alzheimer's disease is treated. With the potential to successfully slow or halt the progression of Alzheimer's, blockbuster revenues are beckoning for such pipeline drugs, claims independent market analyst, Datamonitor.
A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health scientists and colleagues at Mount Sinai's Icahn School of Medicine.
Caffeine is the most widely used psychoactive substance and is part of the daily diet of most people, whether they know it or not. Caffeine is being added to more products, including energy drinks and snack foods, with no regulations requiring the amount of caffeine to be included on the product label.
eClinicalWorks®, a market leader in ambulatory clinical systems, today announced the opening of new locations in Pleasanton, Calif., and New York City, both set to open in October. Currently, the company is headquartered in Westborough, Mass., and has additional offices in New York City and Alpharetta, Ga. The Bay Area location will provide a West coast presence and focus on implementation.
› Verified 4 days ago
Dr. Anthony Joslin, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-652-5000 | |
Dr. Beverly Huszarik, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-652-5000 | |
Dr. Catherine Loniewski Girdler, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-283-1100 Fax: 248-283-1103 | |
Dr. Richard F Nimbach, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-652-5000 | |
Dr. David Bauer, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-652-5000 | |
Dr. Donald Smith, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-652-5454 |